Continuing to execute on its new R&D strategy, GlaxoSmithKline has agreed to buy the rights to a next-generation cancer immunotherapy from Merck.
By merging with Celgene in a record $74 billion deal, Bristol-Meyers will create a formidable organization in the competitive immunotherapy space.
Takeda finally has approval to acquire another large firm, Ireland-based Shire, for $56 billion in the biggest-ever foreign takeover by a Japanese firm.
Boyden's Steve Nilsen interviews David Kerwar, Chief Product Officer and Head of Consumer Digital Innovations at Mount Sinai Health System, as one the country’s leading health systems embraces digital.
Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.
Boyden UK's Industrial Team recently attended the Manufacturing Leaders Summit as part of Digital Manufacturing Week and people have consistently been highlighted as the key to future success.
Boyden's Steve Nilsen spoke to Matt Gove, Piedmont Healthcare’s Chief Consumer Officer, about the new focus on patient experience, and how it’s transforming the role of marketers.
China’s pharmaceutical market offers vast opportunity for multinationals as regulatory and other changes shift the landscape.
Boyden’s Steve Nilsen asked Ascension’s Nick Ragone, Senior Vice President and Chief Marketing and Communications Officer, for his take on healthcare marketing today.
